BNL vs NHI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BNL has a Piotroski F-Score of 6/9, indicating stable financial health, but lacks an Altman Z-Score for distress risk assessment. The stock trades at a significant premium to its Graham Number of $12.7, with a current price of $18.53, supported by a high dividend yield of 6.3% despite a concerning payout ratio of 246.81%. While profitability margins are strong, earnings growth is negative and inconsistent, with recent quarters missing estimates by wide margins. Analysts recommend a 'buy' with a target of $20.18, but technical trends and insider sentiment are weak, suggesting caution despite sector-relative stability.
NHI exhibits a precarious fundamental profile, anchored by a Piotroski F-Score of 4/9, which indicates only marginal stability. The stock is trading at a severe premium to both its Graham Number ($46.26) and its growth-based Intrinsic Value ($21.14), suggesting significant overvaluation. Most concerning is the dividend payout ratio of 120.53%, indicating that the current dividend is unsustainable and not covered by earnings. With negative YoY revenue and earnings growth and a 0/100 technical trend, the data suggests a high risk of price correction.
Compare Another Pair
Related Comparisons
BNL vs NHI: Head-to-Head Comparison
This page compares Broadstone Net Lease, Inc. (BNL) and National Health Investors, Inc. (NHI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.